BIOLIFE SOLUTIONS INC — Director's Dealing 2020

Oct 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-07-17

Reporting Person: Schulz Marcus (Vice President, Global Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-17	Common Stock	A	26624	—	Acquired	41753	Direct
2020-10-12	Common Stock	S	953	$28.20	Disposed	40800	Direct

Footnotes

F1: The restricted stock was granted pursuant to the BioLife Solutions Inc. Second Amended and Restated 2013 Performance Incentive Plan, as amended, and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments.

F2: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.